Telehealth Becomes a Go-To for GLP-1 Users Seeking Weight Loss Medications
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 18 2026
0mins
Source: Bloomberg
Virtual Health Care Demand: Justin Schrieber, CEO of LifeMD, highlights that Americans are increasingly turning to virtual health care providers to access GLP-1 weight loss medication and other prescription drugs.
Untapped Market Potential: Schrieber notes that there remains an untapped market for GLP-1 access, indicating significant growth opportunities in this sector.
Future of Virtual Care: He emphasizes that the next frontier in virtual health care will focus on hormone replacement therapy, suggesting a shift in service offerings.
Source of Information: The insights shared by Schrieber were reported by Bloomberg.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
